0001140361-19-020486.txt : 20191113
0001140361-19-020486.hdr.sgml : 20191113
20191113203108
ACCESSION NUMBER: 0001140361-19-020486
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191108
FILED AS OF DATE: 20191113
DATE AS OF CHANGE: 20191113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CALIFORNIA
CENTRAL INDEX KEY: 0000315054
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 191215954
BUSINESS ADDRESS:
STREET 1: 1111 BROADWAY
STREET 2: 21ST FLOOR
CITY: OAKLAND
STATE: CA
ZIP: 94607-4026
BUSINESS PHONE: 510-987-9600
MAIL ADDRESS:
STREET 1: 1111 BROADWAY
STREET 2: 21ST FLOOR
CITY: OAKLAND
STATE: CA
ZIP: 94607-4026
FORMER NAME:
FORMER CONFORMED NAME: REGENTS OF THE UNIVERSITY OF CA
DATE OF NAME CHANGE: 19600201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4/A
1
form4.xml
FORM 4/A
X0306
4/A
2019-11-08
2019-11-12
true
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0000315054
REGENTS OF THE UNIVERSITY OF CALIFORNIA
1111 BROADWAY, SUITE 2100
OAKLAND
CA
94607
true
Common Stock
2019-11-08
4
S
0
100000
30.25
D
2197406
D
Common Stock
2019-11-08
4
S
0
74316
30.44
D
2123090
D
Common Stock
2019-11-12
4
S
0
12800
32.77
D
2110290
D
Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).
Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.
Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.
/s/ Arthur R. Guimaraes
2019-11-13